Liao Jiannan

Wu Yanxian is presented as a specialist at Fosun Health, holding the role of Director of Cardiology. Fosun Health news describes how he remained on duty throughout the Spring Festival, personally visiting the ICU multiple times to guide management. In that case, the clinical picture included recurrent ischemia and a pseudoaneurysm, and the ICU team monitored ECG changes while tracking cardiac enzyme fluctuations and adjusting nitroglycerin administration. By February 12th, after medication adjustments, the patient’s ECG finally normalized, and the ICU team’s management approach is described as closely coordinated with bedside discussions involving on-call ICU physicians.

Education

Education details are not provided in the available materials.

Work experience

• Director of Cardiology — Fosun Health Hospitals (on duty throughout the Spring Festival; year not specified).
• Director of the Cardiovascular Department — Guangzhou Fosun Chancheng Hospital (as referenced by Fosun Health social coverage).

Clinical focus and techniques

Fosun Health’s clinical coverage frames Dr. Wu Yanxian’s cardiology work around ICU-level monitoring and ECG-guided management.

• ECG monitoring — used to track ischemia signals during inpatient care.
• Medication adjustment guided by bedside monitoring — including nitroglycerin administration adjustments (as described in the case story).

Professional societies and certifications

No professional society memberships or certifications are listed in the provided materials.

Academic output

Academic publication metrics are not listed in the provided materials.

Courses and advanced training

No specific courses or advanced training are listed in the provided materials.

Awards and recognition

Awards are not listed in the provided materials.

Fosun Health’s cardiology coverage emphasizes continuity of care—staying on duty during the Spring Festival and repeatedly visiting the ICU to guide management. His work is linked to ECG-based monitoring and medication adjustment in complex ischemia scenarios, with the clinical endpoint described as ECG normalization after treatment changes.